Clinical Trial Update: Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on mismatched transplantation using high-dose post-transplant cyclophosphamide completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blood Stem Cell Transplant Failure
• Hematologic Malignancies
• Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Blood Stem Cell Transplant Failure, Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2020-01-07